Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Is a |
Product containing piperacillin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Is a |
Product containing piperacillin and tazobactam (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Is a |
Piperacillin with tazobactam |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Piperacillin with tazobactam |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Piperacillin (substance) |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tazobactam |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Is a |
Product containing piperacillin and tazobactam (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Has manufactured dose form |
injection |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tazobactam sodium (substance) |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Piperacillin sodium |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tazobactam |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Has manufactured dose form |
Powder for solution for injection |
true |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
This attribute specifies the denominator unit for the presentation strength of a product. |
Vial (unit of presentation) |
true |
Inferred relationship |
Some |
2 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
This attribute specifies the denominator unit for the presentation strength of a product. |
Vial (unit of presentation) |
true |
Inferred relationship |
Some |
1 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Is a |
Product containing only piperacillin and tazobactam in parenteral dose form (medicinal product form) |
true |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
2 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Has unit of presentation |
Vial (unit of presentation) |
true |
Inferred relationship |
Some |
|
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Tazobactam sodium (substance) |
true |
Inferred relationship |
Some |
2 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Piperacillin (substance) |
true |
Inferred relationship |
Some |
1 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Has presentation strength numerator value |
375 |
false |
Inferred relationship |
Some |
2 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
This attribute specifies the numerator unit for the presentation strength of a product. |
g |
true |
Inferred relationship |
Some |
1 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Tazobactam |
true |
Inferred relationship |
Some |
2 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
2 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Has presentation strength numerator value |
trois |
false |
Inferred relationship |
Some |
1 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Piperacillin sodium |
true |
Inferred relationship |
Some |
1 |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|